Coloplast A/S (OTCMKTS:CLPBY) Upgraded at Hsbc Global Res

Hsbc Global Res upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) from a moderate sell rating to a hold rating in a research report report published on Monday,Zacks.com reports.

Coloplast A/S Trading Down 1.2 %

Shares of OTCMKTS CLPBY opened at $12.60 on Monday. Coloplast A/S has a fifty-two week low of $10.69 and a fifty-two week high of $14.34. The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 1.00. The firm’s 50-day simple moving average is $13.07 and its 200 day simple moving average is $12.86.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.08 earnings per share (EPS) for the quarter. The firm had revenue of $1.02 billion during the quarter. Coloplast A/S had a return on equity of 31.17% and a net margin of 18.69%. As a group, research analysts forecast that Coloplast A/S will post 0.38 EPS for the current fiscal year.

Coloplast A/S Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, December 20th. Stockholders of record on Monday, December 9th will be paid a dividend of $0.2435 per share. This is a boost from Coloplast A/S’s previous dividend of $0.05. The ex-dividend date of this dividend is Monday, December 9th. Coloplast A/S’s dividend payout ratio (DPR) is 27.27%.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.